Add BrightSurf on Google Email

Science News for December 28, 2017


State Medicaid expansions led to more prenatal care for low-income mothers

The study found that expanded Medicaid coverage led to a 2.3% decrease in uninsured rates among pregnant women who already had a child, and a 7.9% decrease in the number of uninsured mothers during pregnancy. Additionally, lower-educated mothers were 1.7% more likely to receive adequate prenatal care due to the expansions.

SourceUniversity of California - Los Angeles Health Sciences·JournalHealth Services Research·DateDec 28, 2017

Ophthalmologists report increased use of electronic health records but decreased productivity as a result

A survey of 348 US ophthalmologists found that EHR adoption has more than doubled since 2011 to 72 percent. Despite this growth, most ophthalmologists reported a decrease in productivity as a result of EHR use. This study emphasizes the need for improving the efficiency and usability of EHR systems to mitigate negative perceptions.

SourceJAMA Network·JournalJAMA Ophthalmology·DateDec 28, 2017

Cholera hotspots found at Uganda's borders and lakes

Researchers have identified 22 high-risk districts in Uganda where cholera outbreaks are more likely due to proximity to international borders and bodies of water. These districts are recommended for strengthened collaboration with neighboring countries to control the spread of cholera.

SourcePLOS·JournalPLOS Neglected Tropical Diseases·DateDec 28, 2017

Double strike against tuberculosis

Researchers at TUM and Harvard University discovered a substance that interferes with the formation of Mycobacterium tuberculosis' mycomembrane. Combining this beta-lactone inhibitor with known antibiotics increases effectiveness by up to 100-fold, making it a promising new therapy for TB.

SourceTechnical University of Munich (TUM)·JournalAngewandte Chemie International Edition·DateDec 28, 2017

Carfilzomib can lead to cardiovascular toxicity in multiple myeloma patients

A new study from the University of Pennsylvania School of Medicine found that 18% of multiple myeloma patients experiencing cardiovascular adverse events (CVAE) such as hypertension, heart failure, or arrhythmia. Higher doses of carfilzomib are associated with higher rates of CVAE, and the drug is linked to an elevated risk of CVAE com...